# A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects

> **NCT07084961** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Adult Male Subjects

## Interventions

- **DRUG:** TS-172
- **DRUG:** TS-172

## Key facts

- **NCT ID:** NCT07084961
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-05
- **Primary completion:** 2025-09-11
- **Final completion:** 2025-09-16
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07084961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07084961, "A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07084961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*